Trevena, Inc.
(NASDAQ : TRVN)

( )
TRVN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.10%176.471.2%$601.40m
GILDGilead Sciences, Inc.
-0.57%67.630.9%$539.35m
BIIBBiogen Inc.
-0.97%277.671.2%$514.24m
CELGCelgene Corporation
-4.70%74.691.2%$489.59m
REGNRegeneron Pharmaceuticals, Inc.
-1.73%296.602.6%$311.33m
ALXNAlexion Pharmaceuticals, Inc.
-1.40%119.372.0%$249.70m
ILMNIllumina, Inc.
-0.51%268.293.5%$243.07m
VRTXVertex Pharmaceuticals Incorporated
-0.65%156.221.9%$235.00m
NKTRNektar Therapeutics
-2.15%83.476.0%$207.63m
AAgilent Technologies, Inc.
1.91%65.551.5%$202.86m
INCYIncyte Corporation
-1.53%66.792.5%$191.53m
SRPTSarepta Therapeutics, Inc.
-2.84%90.8316.6%$127.57m
EXASExact Sciences Corporation
-0.13%52.2925.5%$115.91m
BMRNBioMarin Pharmaceutical Inc.
0.54%89.364.4%$115.05m
ALNYAlnylam Pharmaceuticals, Inc
-1.96%100.809.8%$101.63m

Company Profile

Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.